Omega Diagnostics Group PLC Receipt of deferred consideration (5537H)

TIDMODX

RNS Number : 5537H

Omega Diagnostics Group PLC

25 November 2022

OMEGA DIAGNOSTICS GROUP PLC

("Omega" or the "Company" or the "Group")

Receipt of deferred consideration

Omega (AIM: ODX), the specialist medical diagnostics company focused on promoting a personalised and functional approach to health and nutrition, announces that it has now received the GBP4.0m of deferred consideration relating to the sale of the CD4 business.

Accordingly, as of close of business on 24 November 2022, Omega held cash balances of GBP6.5m.

The information communicated in this announcement is inside information for the purposes of Article 7 of EU Regulation 596/2014.

Contacts:

 
  Omega Diagnostics Group PLC                            www.omegadiagnostics.com 
  Jag Grewal, Chief Executive                                     via Walbrook PR 
  Chris Lea, Chief Financial 
   Officer 
 
  finnCap Ltd                                                  Tel: 020 7220 0500 
  Geoff Nash/Edward Whiley (Corporate 
   Finance) 
  Alice Lane/ Harriet Ward (ECM) 
 
  Walbrook PR Limited                  Tel: 020 7933 8780 or omega@walbrookpr.com 
  Paul McManus / Sam Allen                Mob: 07980 541 893 / Mob: 07502 558 258

About Omega Diagnostics Group PLC

Omega (AIM: ODX) is a specialist medical diagnostics company focused on promoting a personalised and functional approach to health and nutrition.

www.omegadx.com

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

MSCFEFFMLEESEIF

(END) Dow Jones Newswires

November 25, 2022 02:00 ET (07:00 GMT)

Omega Diagnostics (LSE:ODX)
Historical Stock Chart
From Mar 2024 to Apr 2024